Cannabis consumption as a prognostic factor in schizophrenia.
M J Martinez-Arevalo, A Calcedo-Ordoñez, J R Varo-Prieto
The British journal of psychiatry : the journal of mental science May 1994 DOI: 10.1192/bjp.164.5.679 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational follow-up study Peer reviewed |
|---|---|
| Sample size | 62 |
| Population | Schizophrenic patients aged 18 to 30 treated at community mental health centres in Navarra who had relapsed |
| Duration | One-year follow-up |
| Topics | Cannabis |
| Key findings | Among 62 young schizophrenia patients in Navarra who relapsed and were followed for one year, the course of illness was influenced by continued cannabis consumption, previous cannabis intake, non-compliance with treatment, and stress. |
Abstract
Data were analysed from 62 schizophrenic patients between 18 and 30 years of age, treated at the community mental health centres in Navarra, who had relapsed and then completed a one-year follow-up study. Factors influencing the course of illness during follow-up were: continuing cannabis consumption; previous cannabis intake; non-compliance with treatment; and stress.